Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 1.00 |
| ▸ | MEN1 | O00255 | 1/20 | 0.64 |
| ▸ | LMNA | P02545 | 1/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.64 |
| ▸ | MAPT | P10636 | 2/20 | 0.60 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.59 |
| ▸ | THRB | P10828 | 1/20 | 0.59 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.59 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.59 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.59 |
| ▸ | THPO | P40225 | 1/20 | 0.59 |
| ▸ | RECQL | P46063 | 1/20 | 0.59 |
| ▸ | BLM | P54132 | 1/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.59 |
| ▸ | FOLH1 | Q04609 | 9/20 | 0.56 |
| ▸ | LAP3 | P28838 | 3/20 | 0.53 |
| ▸ | NAALAD2 | Q9Y3Q0 | 2/20 | 0.52 |
| ▸ | PLA2G2A | P14555 | 2/20 | 0.50 |
| ▸ | PLA2G5 | P39877 | 2/20 | 0.50 |
| ▸ | GRN | P28799 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Levacetylleucine SCHEMBL9438432 | 1.00 | ALDH1A1 (1.00) | ALDH1A1MEN1LMNAKMT2AMAPT | |
| Levacetylleucine SCHEMBL282372 | 1.00 | ALDH1A1 (1.00) | ALDH1A1MEN1LMNAKMT2AMAPT | |
| Acetylleucine SCHEMBL282371 | 1.00 | ALDH1A1 (1.00) | ALDH1A1MEN1LMNAKMT2AMAPT | |
| Levacetylleucine SCHEMBL5527234 | 0.98 | ALDH1A1 (0.96) | ALDH1A1MEN1LMNAKMT2AMAPT | |
| Levacetylleucine SCHEMBL18954336 | 0.98 | ALDH1A1 (0.96) | ALDH1A1MEN1LMNAKMT2AMAPT | |
| Levacetylleucine SCHEMBL7923132 | 0.98 | ALDH1A1 (0.96) | ALDH1A1MEN1LMNAKMT2AMAPT | |
| Levacetylleucine SCHEMBL5532016 | 0.98 | ALDH1A1 (0.96) | ALDH1A1MEN1LMNAKMT2AMAPT | |
| Acetylleucine SCHEMBL25408262 | 0.94 | ALDH1A1 (0.88) | ALDH1A1MEN1LMNAKMT2AMAPT | |
| Levacetylleucine SCHEMBL6863674 | 0.92 | ALDH1A1 (0.85) | ALDH1A1MEN1LMNAKMT2AMAPT | |
| SCHEMBL17948650 | 0.92 | ALDH1A1 (0.85) | ALDH1A1MEN1LMNAKMT2AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 636 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3375771-B1 | METHOD FOR PRODUCING LACOSAMIDE AND INTERMEDIATE THEREOF | UBE CORP (JP) | 2025-11-26 | — | — | EP | claimed |
| US-12441774-B2 | Molecular guide system peptides and uses thereof | SRI INTERNATIONAL (US) | 2025-10-14 | — | — | US | claimed |
| US-20250312302-A1 | COMPOSITIONS AND METHODS FOR TREATING NEURODEVELOPMENTAL DISORDERS | SYNGAP RES FUND (US) | 2025-10-09 | — | — | US | claimed |
| EP-4608828-A1 | IMPROVED PROCESSES FOR PREPARING DIMETHYL-2,3-DIHYDRO-1H-INDENE DERIVATIVES | Yuhan Corporation (KR) | 2025-09-03 | — | — | EP | claimed |
| US-12403111-B2 | Compositions and methods for treating neurodevelopmental disorders | SynGAP Research Fund (US) | 2025-09-02 | — | — | US | claimed |
| US-20250270187-A1 | MOLECULAR EDITING OF MULTIPLE C-H BONDS LEVERAGING RECOGNITION OF DISTANCE, GEOMETRY AND CHIRALITY | THE SCRIPPS RESEARCH INSTITUTE | 2025-08-28 | — | — | US | claimed |
| US-20250248959-A1 | COMPOSITIONS AND METHODS FOR TREATING NEURODEVELOPMENTAL DISORDERS | UNIVERSITY OF UTAH RESEARCH FOUNDATION | 2025-08-07 | — | — | US | claimed |
| CN-119923397-A | Improved process for preparing dimethyl-2, 3-dihydro-1H-indene derivatives | 柳韩洋行 | 2025-05-02 | — | — | CN | claimed |
| US-20250100999-A1 | METHODS AND INTERMEDIATES FOR PREPARING THERAPEUTIC COMPOUNDS | GILEAD SCIENCES, INC. | 2025-03-27 | — | — | US | claimed |
| CN-114262704-B | Immobilized carrier, D-acetylleucine deacetylation immobilized enzyme and preparation method | 亿利耐雀生物科技有限公司 | 2024-11-01 | — | — | CN | claimed |
| US-6514742-B1 | Given physico-chemical properties; from fungi; use to deacetylate N-acetyl-D-amino acids | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2003-02-04 | — | — | US | claimed |
| US-20020151035-A1 | D-aminoacylase and gene encoding the same | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2002-10-17 | — | — | US | claimed |
| US-20020090713-A1 | Enzymatic polypeptide for generating preferential amino acids | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2002-07-11 | — | — | US | claimed |
| EP-1178114-A2 | Heat-stable d-aminoacylase | Daicel Chemical Industries, Ltd. (JP) | 2002-02-06 | — | — | EP | claimed |
| EP-1120465-A1 | D-Aminoacylase and gene encoding the same | Daicel Chemical Industries, Ltd. (JP) | 2001-08-01 | — | — | EP | claimed |
| US-6030823-A | FOR INDUSTRIAL PRODUCTION OF D-AMINO ACIDS FROM N-ACETYL-D-AMINO ACIDS | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2000-02-29 | — | — | US | claimed |
| EP-0976828-A1 | Fungal D-aminoacylases and method for producing D-amino acids | DAICEL CHEMICAL INDUSTRIES, Ltd. (JP) | 2000-02-02 | — | — | EP | claimed |
| EP-0950706-A2 | D-aminoacylase | DAICEL CHEMICAL INDUSTRIES, Ltd. (JP) | 1999-10-20 | — | — | EP | claimed |
| US-5916774-A | PRODUCES D-AMINO ACIDS FROM CORRESPONDING N-ACETYL-D-AMINO ACIDS; ACTIVITY PROMOTED BY COBALT AND CALCIUM IONS BUT INHIBITED BY COPPER, MERCURY AND ZINC IONS | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 1999-06-29 | — | — | US | claimed |
| EP-0896057-A2 | D-aminoacylase | DAICEL CHEMICAL INDUSTRIES, Ltd. (JP) | 1999-02-10 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250248959-A1 | COMPOSITIONS AND METHODS FOR TREATING NEURODEVELOPMENTAL DISORDERS | SLC1A2, CHAT, BDNF | ALDH1A1 629/4885MEN1 4188/4885LMNA 2838/4885 |
| US-20250312302-A1 | COMPOSITIONS AND METHODS FOR TREATING NEURODEVELOPMENTAL DISORDERS | SLC1A2, CHAT, BDNF | ALDH1A1 629/4885MEN1 4188/4885LMNA 2838/4885 |
| US-12403111-B2 | Compositions and methods for treating neurodevelopmental disorders | SLC1A2, CHAT, BDNF | ALDH1A1 629/4885MEN1 4188/4885LMNA 2838/4885 |
| US-20020090713-A1 | Enzymatic polypeptide for generating preferential amino acids | DNPEP, NAALAD2, DAO | ALDH1A1 663/4885MEN1 2863/4885LMNA 3299/4885 |
| US-20250270187-A1 | MOLECULAR EDITING OF MULTIPLE C-H BONDS LEVERAGING RECOGNITION OF DISTANCE, GEOMETRY AND CHIRALITY | CYCS, CYC1, CDA | ALDH1A1 222/4885MEN1 4381/4885LMNA 2697/4885 |
| US-20250100999-A1 | METHODS AND INTERMEDIATES FOR PREPARING THERAPEUTIC COMPOUNDS | CYP11A1, CYP11B1, CYP11B2 | ALDH1A1 1161/4885MEN1 1057/4885LMNA 1143/4885 |
| US-20020151035-A1 | D-aminoacylase and gene encoding the same | NAALAD2, AANAT, DAO | ALDH1A1 1209/4885MEN1 2048/4885LMNA 3964/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.